ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,963Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 244

$277 Total Retail Price of All Prescriptions

Rank: 244 out of 244

210 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 210 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,618 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$0 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
ASPIRIN EC 658 632 1 63
SIMVASTATIN 573 550 2 1
AMLODIPINE BESYLATE 472 458 3 2
VITAMIN D 443 426 10 4 123
METOPROLOL SUCCINATE 283 270 5 11
HYDROCHLOROTHIAZIDE 218 196 6 12
DONEPEZIL HCL 207 204 7 9
ENALAPRIL MALEATE 207 207 7 24
METFORMIN HCL 205 187 9 10
FUROSEMIDE 168 165 10 3
THERA-M 158 158 10 11 223
ATORVASTATIN CALCIUM 141 125 12 17
METOPROLOL TARTRATE 139 134 13 5
DOCUSIL 133 131 10 14 139
NAMENDA 120 120 15 19
OYSTER SHELL CALCIUM 119 119 10 16 236
PAIN & FEVER 104 104 10 17 210
CYANOCOBALAMIN INJECTION 99 99 18 229
SENNA-GEN 94 90 19 165
GABAPENTIN 91 81 20 14
LANTUS SOLOSTAR 86 71 21 91
DAILY VITE 84 84 22 180
FISH OIL 81 70 23 258
NOVOLOG MIX 70-30 FLEXPEN 81 81 23 262
LOSARTAN POTASSIUM 78 78 25 16
GLIMEPIRIDE 76 76 26 71
INSULIN SYRINGE 75 67 27 128
PRANDIN 72 69 28 111
NIFEDIPINE ER 69 69 29 64
LISINOPRIL 67 65 30 7
OYSCO 500+D 64 64 10 31 292
LEVOTHYROXINE SODIUM 63 63 32 4
MAPAP 63 60 32 189
TRAMADOL HCL 61 61 34 53
DIOVAN 57 57 35 37
ATENOLOL 55 55 36 18
DOK 55 54 36 363
EASY TOUCH 55 48 36 292
CLOTRIMAZOLE 54 51 39 205
GLIPIZIDE 54 54 39 42
OMEPRAZOLE 53 53 41 6
CILOSTAZOL 52 37 42 175
NOVOFINE 51 51 43 381
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.